Doctor profile · Federal record
Dr. Robin Vancleave, P.A.
Specialist (CMS: Physician Assistant) · Oklahoma City, OK
- NPI 1609099886
- Accepts Medicare
- MIPS 81.6 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
11200 N Portland Ave, 2Nd
Oklahoma City, OK 731205045
(405) 936-1000
fax (405) 936-1001
Credentials & registration
- NPI registered
- April 2007 — 19 yrs on file
- Profile last updated
- November 14, 2011
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Oklahoma #1195
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609099886. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,122
Distinct HCPCS
8
Medicare allowed
$28,786
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 840 | 13 | $23 | |
G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 91 | 91 | $18 | |
G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination | 75 | 75 | $31 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 45 | 39 | $68 | |
96372 |
Injection of drug or substance under skin or into muscle | 26 | 14 | $11 | |
Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 17 | 17 | $34 | |
81003 |
Automated urinalysis test | 14 | 13 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 14 | 12 | $96 |
In context: peer comparison
Among 6 peers in Oklahoma City Specialist, average services per provider: 317. This provider delivers 3.5× the peer median.Open Payments
Industry payments received
All-time total
$655
Transactions
43
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Mayne Pharma Commercial LLC | 13 | $208.83 | |
| Astellas Pharma US INC | 12 | $139.23 | |
| Organon LLC | 7 | $89.74 | |
| Hologic Sales and Service, LLC | 3 | $61.57 | |
| Millicent US INC | 2 | $38.59 | |
| Sumitomo Pharma America, INC. | 2 | $37.17 | |
| Radius Health, INC. | 1 | $23.36 | |
| Agile Therapeutics, INC. | 1 | $22.71 | |
| Bayer Healthcare Pharmaceuticals INC. | 1 | $17.34 | |
| Amgen INC. | 1 | $16.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
447
Patients
99
Total drug cost
$38,064
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Estradiol | Generic | 122 | 43 | $4,610 |
| Zolpidem Tartrate | Generic | 46 | 0 | $297 |
| Progesterone (Progesterone, Micronized) | Brand | 41 | 14 | $2,350 |
| Myrbetriq (Mirabegron) | Brand | 39 | 0 | $21,087 |
| Fluconazole | Generic | 37 | 16 | $215 |
| Estradiol (Twice Weekly) (Estradiol) | Brand | 26 | 0 | $2,641 |
| Medroxyprogesterone Acetate | Generic | 19 | 0 | $432 |
| Estradiol (Once Weekly) (Estradiol) | Brand | 18 | 0 | $2,278 |
| Hydrocortisone | Generic | 16 | 0 | $239 |
| Nitrofurantoin Mono-Macro (Nitrofurantoin Monohyd/M-Cryst) | Brand | 16 | 14 | $263 |
Hospital affiliations
Frequently asked questions
What is Dr. Robin Vancleave's medical specialty?
Dr. Robin Vancleave practices Specialist in Oklahoma City, OK.
Where does Dr. Robin Vancleave practice?
Dr. Robin Vancleave practices at 11200 N Portland Ave, Oklahoma City, OK 731205045. Office phone: 4059361000.
What is Dr. Robin Vancleave's NPI?
Dr. Robin Vancleave's National Provider Identifier (NPI) is 1609099886, issued by NPPES.
Does Dr. Robin Vancleave accept Medicare assignment?
Yes. Dr. Robin Vancleave accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Robin Vancleave commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS G0328); Cervical or vaginal cancer screening; pelvic and clinical breast examination (HCPCS G0101). Source: CMS Medicare Physician & Other Practitioners file.